2016
DOI: 10.3389/fped.2016.00051
|View full text |Cite
|
Sign up to set email alerts
|

Relevant Outcomes in Pediatric Acute Respiratory Distress Syndrome Studies

Abstract: Despite distinct epidemiology and outcomes, pediatric acute respiratory distress syndrome (PARDS) is often managed based on evidence extrapolated from treatment of adults. The impact of non-pulmonary processes on mortality as well as the lower mortality rate compared to adults with acute respiratory distress syndrome (ARDS) renders the utilization of short-term mortality as a primary outcome measure for interventional studies problematic. However, data regarding alternatives to mortality are profoundly underst… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
24
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 38 publications
(25 citation statements)
references
References 70 publications
1
24
0
Order By: Relevance
“…Our mortality results agree with those of previous studies[4-10], though it has been argued that mortality in PARDS is usually secondary to non-pulmonary causes, making it unsurprising that improved oxygenation would have little effect on overall mortality[28]. However, previous studies did not evaluate for morbidity effects and selectively excluded certain populations of patients—such as those with immunocompromise, sepsis, and multisystem organ dysfunction—from analysis, which limits generalizability of the results to a significant portion of PICU patients[29, 30].…”
Section: Discussionsupporting
confidence: 91%
“…Our mortality results agree with those of previous studies[4-10], though it has been argued that mortality in PARDS is usually secondary to non-pulmonary causes, making it unsurprising that improved oxygenation would have little effect on overall mortality[28]. However, previous studies did not evaluate for morbidity effects and selectively excluded certain populations of patients—such as those with immunocompromise, sepsis, and multisystem organ dysfunction—from analysis, which limits generalizability of the results to a significant portion of PICU patients[29, 30].…”
Section: Discussionsupporting
confidence: 91%
“…Patients who required ≥28 ventilator days and all ICU non-survivors were designated as VFD=0. This composite endpoint, which incorporates both mortality and length of ventilation by penalizing non-survivors, is among the most commonly used surrogate endpoints in recent PARDS studies [18].…”
Section: Methodsmentioning
confidence: 99%
“…[78][79][80] We did not find a trend toward reporting nonmortality outcomes as income level increased, in contrast to high-income countries that have transitioned to reporting predominantly non-mortality outcomes. [81][82][83] This could reflect high mortality rates in upper middle income countries, making death still the most relevant outcome. Alternatively, it may reflect differences in facility-level resources and mortality risk independent of country income level, given known differences in within-country resource availability and access to care.…”
Section: Discussionmentioning
confidence: 99%